ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.38
0.12%
US Tech 100
21,213.60
1.06%
S&P 500
6,086.37
0.61%
US Dollar vs CAD
1.43935
0.00%
Bitcoin
102,454.92
-1.14%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Fagron NV (FAGR) Share Price

Fagron NV

Fagron NV (FAGR)

Wt Agricultu Ld
18.10
-0.04
(-0.22%)
Closed January 22 10:30AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
18.10
Bid
18.00
Ask
18.16
Volume
25,955
18.04 Day's Range 18.20
15.14 52 Week Range 20.05
Market Cap
1.321B
Previous Close
18.14
Open
18.14
Last Trade
178
@
18.1
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
70,466
Shares Outstanding
72,987,000
Dividend Yield
-
PE Ratio
18.73
Earnings Per Share (EPS)
0.97
Revenue
766.48M
Net Profit
70.55M

About Fagron NV

Sector
Health & Allied Services,nec
Industry
Health & Allied Services,nec
Website
www.fagron.com
Headquarters
Roermond, Limburg, Nld
Founded
-
Fagron NV is listed in the Health & Allied Services sector of the Euronext with ticker FAGR. The last closing price for Fagron NV was 18.14 €. Over the last year, Fagron NV shares have traded in a share price range of 15.14 € to 20.05 €.

Fagron NV currently has 72,987,000 shares outstanding. The market capitalization of Fagron NV is 1.32 € billion. Fagron NV has a price to earnings ratio (PE ratio) of 18.73.

Ask ADVFN Intelligence (AI)

FAGR Latest News

More News

Fagron strengthens its market positioning with the acquisitions of CareFirst in North America and Injeplast in Brazil

Fagron strengthens its market positioning with the acquisitions of CareFirst in North America and Injeplast in Brazil Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 7 Jan...

January 07 2025
UK Regulatory

Fagron updates on FDA communication regarding the June 2024 inspection at Wichita

Fagron updates on FDA communication regarding the June 2024 inspection at Wichita Regulated information – inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 23 Dec 2024 – 7AM CET...

December 23 2024
UK Regulatory

Disclosure of notification received from FMR LLC

Disclosure of notification received from FMR LLC Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 26 November 2024 – 6.45 PM CET Disclosure of notification received from FMR...

November 26 2024
UK Regulatory

Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook

Fagron reports outstanding third quarter 2024 performance with 12.1% revenue growth and reaffirms full-year outlook Regulated information - inside informationNazareth (Belgium)/Rotterdam (The...

October 10 2024
UK Regulatory

Disclosure of notification received from AOC Pharma S.à r.l.

Disclosure of notification received from AOC Pharma S.à r.l. Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 8 October 2024 – 9:00 PM CET Disclosure of notification received...

October 08 2024
UK Regulatory

Fagron completes share buy-back program

Fagron completes share buy-back program Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 13 September 2024 – 6PM CET Fagron completes share buy-back program Fagron has...

September 13 2024
UK Regulatory

Fagron’s share buy-back program: Weekly update

Fagron’s share buy-back program: Weekly update Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 September 2024 – 6PM CET Fagron’s share buy-back program: Weekly update In...

September 06 2024
UK Regulatory

Fagron’s share buy-back program: Weekly update

Fagron’s share buy-back program: Weekly update Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 30 August 2024 – 6PM CET Fagron’s share buy-back program: Weekly update In the...

August 30 2024
UK Regulatory

Fagron’s share buy-back program: Weekly update

Fagron’s share buy-back program: Weekly update Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 23 August 2024 – 6PM CET Fagron’s share buy-back program: Weekly update In the...

August 23 2024
UK Regulatory

Fagron delivers strong performance with 16% topline growth and 17% increase in REBITDA for the first half of 2024

Fagron delivers strong performance with 16% topline growth and 17% increase in REBITDA for the first half of 2024 Regulated information - inside informationNazareth (Belgium)/Rotterdam (The...

August 01 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.48.3832335329316.718.5216.647871317.67112555DE
41.48.3832335329316.718.5216.386373117.10415512DE
12-0.56-3.0010718113618.6619.2615.147046617.98939062DE
26-0.6-3.2085561497318.720.0515.146410718.42109659DE
521.458.7087087087116.6520.0515.145813918.17668416DE
1562.6517.152103559915.4520.0510.87920515.86241547DE
260-2.42-11.793372319720.5223.2610.89612017.18632237DE

FAGR - Frequently Asked Questions (FAQ)

What is the current Fagron NV share price?
The current share price of Fagron NV is 18.10 €
How many Fagron NV shares are in issue?
Fagron NV has 72,987,000 shares in issue
What is the market cap of Fagron NV?
The market capitalisation of Fagron NV is EUR 1.32B
What is the 1 year trading range for Fagron NV share price?
Fagron NV has traded in the range of 15.14 € to 20.05 € during the past year
What is the PE ratio of Fagron NV?
The price to earnings ratio of Fagron NV is 18.73
What is the cash to sales ratio of Fagron NV?
The cash to sales ratio of Fagron NV is 1.72
What is the reporting currency for Fagron NV?
Fagron NV reports financial results in EUR
What is the latest annual turnover for Fagron NV?
The latest annual turnover of Fagron NV is EUR 766.48M
What is the latest annual profit for Fagron NV?
The latest annual profit of Fagron NV is EUR 70.55M
What is the registered address of Fagron NV?
The registered address for Fagron NV is FASCINATIO BOULEVARD350, ROERMOND, LIMBURG, 3065 WB
What is the Fagron NV website address?
The website address for Fagron NV is www.fagron.com
Which industry sector does Fagron NV operate in?
Fagron NV operates in the HEALTH & ALLIED SERVICES,NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALMASMastrad
0.0218 €
(122.45%)
24.21M
MLAATAzorean Tech
0.16 €
(60.00%)
1.05k
CDUConduril Engenharia SA
24.60 €
(30.16%)
150
ALNMRNamR SA
0.1745 €
(29.74%)
46.73k
ALSPWSpineway
0.129 €
(28.87%)
960.57k
MLWEYWeya
0.02 €
(-23.08%)
1.5k
ALNEVNeovacs
0.503 €
(-18.87%)
15.62k
ALBIOBiosynex
1.65 €
(-18.32%)
53.17k
POXELPoxel
0.324 €
(-17.03%)
2.44M
ALVETEGEIRO Pharma
0.0912 €
(-16.33%)
4.95k
ATOAtos SE
0.0022 €
(0.00%)
301.81M
BCPBanco Comercial Portugues SA
0.5132 €
(0.16%)
35.61M
ALMASMastrad
0.0218 €
(122.45%)
24.21M
ALVERVergnet
0.0014 €
(0.00%)
17.57M
ALCYBCybergun
0.0001 €
(0.00%)
15.68M

Discussion

View Full Feed
littlejohn littlejohn 4 minutes ago
SMCI rally up, new litigation against BDO

may be the next fud coming to take

a swing at bringing price down...

Hopefully that would be the worst fud

that we see with improved action...

Around $29ish still needs defending by
SMCI
Guido2 Guido2 9 minutes ago
He wants to hold hands with Ackerman, Carney and Light to see him through the dark hours. Unfortunately, he only has two hands.
FNMA
jour_trader jour_trader 14 minutes ago
Minutes posted from call, but behind a paywall. 

https://www.pacermonitor.com/public/case/51356241/PURDUE_PHARMA_LP_et_al_v_ELITE_LABORATORIES_INC,_et_al
ELTP
ace65 ace65 19 minutes ago
When the pigs at the trough get their fill we will have a
HMBL type run.
And the pause of ongoing dilution of course.
HMBL
Dumb&dumber4long Dumb&dumber4long 20 minutes ago
Let’s focus on TNXP, stick politics somewhere else & other subjects too.
TNXP
22rover 22rover 20 minutes ago
It's important to remember that legacy holders have invested at or above 0.18 cents. If they are not following sidechannel’s progress, the reality they see is a thinly traded penny stock lingering near its all-time lows.

They phone their broker to sell the stock. Broker says, yeah, i
SDCH
pegs1 pegs1 21 minutes ago
I think it’s very unprofessional for management to not inform investors of the closing of the lab including departure of scientists! This just continues to be full of surprises ……
CRTG
gp22 gp22 23 minutes ago
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
gp22 gp22 24 minutes ago
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
gp22 gp22 24 minutes ago
ASNS: AI infrastructure stocks are getting hot coming off the massive $ORCL AI Infrastucture deal just announced.
$ASNS the cheapest microfloat AI Infrastructure stock. Top management. Starting to rip. Has recent upgrade from highly regarded Litchfield. Do not miss $ASNS.
$ASNS has 6K
ASNS BFAI ORCL
SkyLimit2022 SkyLimit2022 27 minutes ago
suit,

Thanks for posting the MHRA link!
https://investorshub.advfn.com/uimage/uploads/2024/10/21/zqal[200.gif
https://investorshub.advfn.com/uimage/uploads/2024/10/24/nqdtigiphy.gif

That’s exactly the kind of regulatory support that Advent has provided wh
NWBO
noradio noradio 27 minutes ago
Pm'd
DBMM
AlwaysOptimistic AlwaysOptimistic 28 minutes ago
I agree with you NorCal. Either the current mgt delivers financing this year or just sell the mine as you suggested to a large mining co that can deliver results. Many of us are stuck with shares that have fallen to lows that are not even worth selling. Would like to see a rebound and recoup our or
NB
The GidDy uP Kid The GidDy uP Kid 31 minutes ago
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
The GidDy uP Kid The GidDy uP Kid 31 minutes ago
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
The GidDy uP Kid The GidDy uP Kid 32 minutes ago
CNSP, readying for a Bullish Hammer tomorrow… 
https://schrts.co/cBIMqiew
CNSP
harry crumb harry crumb 33 minutes ago
Lets see 1.50 tomorrow or lower boys! Jam it at open! Lets roll $$$$$$
ILLR
XMaster2023 XMaster2023 34 minutes ago
Theory, Approval of DCVax is near!
NWBO
Plato_ Plato_ 35 minutes ago
Yup, that's the way I understand it. Whether the contract is paid up front or on performance, the revenue is recognized when earned and deferred revenue is reduced to match. Good example with the labor-based contract. Same principle. You make a good point about the intellectual property. If this is
GDVM
boi568 boi568 35 minutes ago
Statutes and regulations will always trump guidances, assuming the statutes or regulations address the issue the guidance is addressing. The reason agencies issue guidance is because the statutes and regulations haven't addressed the issue.

So, if you can find an FDA statute or regula
AVXL
boi568 boi568 35 minutes ago
Statutes and regulations will always trump guidances, assuming the statutes or regulations address the issue the guidance is addressing. The reason agencies issue guidance is because the statutes and regulations haven't addressed the issue.

So, if you can find an FDA statute or regula
AVXL
3331 3331 36 minutes ago
3331 has been restricted to one post per day:

BIEL HITS COPPER "IN THE BLINK OF AN EYE" WHEN THE FOLLOWING OCCURS!

pps > .001 after management drops some positive hints. The Golden Cross (already achieved) and Blue Sky Breakout will get the technicians/chartists attenti
QUBT SERV
theorysuit theorysuit 37 minutes ago
https://cms.mhra.gov.uk/mhra/mia/uk-miaimp-54923

Oh you are talking about this MIA. Unfortunately, i only see ADVENT on this MIA. No sight of NWBO at all. Like i said congrats to LP not NWBO.


https://find-and-update.company-information.service.gov.uk/company
NWBO
HomerRomer HomerRomer 38 minutes ago
This is a response to Missling’s LinkedIn post by a VERY educated and qualified senior vice president of Red Nucleus who manages and provides strategic oversight and tactical back up for clinical teams.  He seems to think Blarcamesine  could likely work better than the study results show. 
AVXL

Your Recent History

EU
FAGR
Fagron NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads